Interventions in the signaling pathways initiated by the TGF-β family of proteins, including TGF-β and bone morphogenetic proteins (BMPs), may therefore have important therapeutic potential for BPD (Morty et al., 2009). The gene discussed is TGFB1; the disease is bronchopulmonary dysplasia.